Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

Part of paid clinical trials in Dallas, Texas.

Sponsor
University of Texas Southwestern Medical Center
Study ID
NCT01808937
Status
Recruiting
Apply to this trial

Conditions

  • Frontal Linear Scleroderma en Coup de Sabre
  • Morphea
  • Scleroderma, Circumscribed
  • Scleroderma, Linear
  • Scleroderma, Localized

Eligibility Criteria

Sex
ALL
Age
N/A - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Morphea — OTHER

Study Details

The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific problems occur along with morphea (for example, arthritis) * Whether morphea has an autoimmune background

Key Dates

Start date
May 31, 2007
Status verified
May 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Morphea
    Those having the condition morphea or other synonymous diagnosis (such as localized scleroderma, linear scleroderma, Parry-Romberg syndrome, en coup de sabre)

Primary Outcome Measure

Activity/damage measurement in morphea as scored on the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT Southwestern Medical Center - Department of DermatologyDallasTexas75390-9069
Heidi Jacobe, MD, MSCS
[email protected]
214.633.1837
Heidi Jacobe, MD, MSCS (PRINCIPAL_INVESTIGATOR)

Find similar trials in Dallas, TX

By research site
UT Southwestern Medical Center - Department of Dermatology· Dallas, TX